The board of directors of JW (Cayman) Therapeutics Co. Ltd. announced that Mr. Xin Fu has tendered his resignation as chief financial officer of the Company with effect from December 15, 2023, due to his personal career development. Mr. Fu has confirmed that he has no disagreement with the Board and there are no matters in relation to his resignation that need to be brought to the attention of the shareholders of the Company or The Stock Exchange of Hong Kong Limited.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.94 HKD | +2.11% | -1.02% | -14.16% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.16% | 100M | |
+16.61% | 122B | |
+17.75% | 112B | |
+17.23% | 25.91B | |
-24.11% | 19.33B | |
-18.56% | 16.17B | |
-18.47% | 15.6B | |
-47.75% | 14.65B | |
+57.35% | 14.34B | |
+5.62% | 14B |
- Stock Market
- Equities
- 2126 Stock
- News JW (Cayman) Therapeutics Co. Ltd
- JW Therapeutics Co. Ltd Announces Resignation of Xin Fu as Chief Financial Officer